Palm Beach, FL 6/28/12 (StreetBeat) -- Shares of Synergetics USA Inc (Nasdaq: SURG) jumped nearly 50 percent on Thursday after U.S. health regulators granted marketing approval for the company's eye surgery device.
The U.S. Food and Drug Administration on Wednesday approved VersaVIT - a device to remove liquid from inside the eye during a surgery.
The company said it was waiting for a similar approval from European health authorities.
Synergetics shares, which have lost nearly 50 percent of their value so far this year, touched a more than one-month high of $5.75 in early trading. The company's stock was the top percentage gainer on the Nasdaq.
Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail firstname.lastname@example.org or call (662) 392-0740 for pricing and scheduling.